- Report
- January 2025
- 375 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- November 2024
- 150 Pages
Global
From €4604EUR$4,850USD£3,884GBP
- Report
- May 2024
- 130 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Report
- May 2024
- 138 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Drug Pipelines
- August 2024
- 180 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- February 2025
- 183 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Drug Pipelines
- April 2024
- 180 Pages
Global
From €2848EUR$3,000USD£2,402GBP
- Drug Pipelines
- April 2024
- 100 Pages
Global
From €2848EUR$3,000USD£2,402GBP
- Report
- August 2024
- 150 Pages
Global
From €2648EUR$2,789USD£2,233GBP
- Report
- November 2024
- 257 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- February 2024
- 250 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- February 2024
- 250 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- June 2023
- 180 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- June 2021
- 50 Pages
China
From €2468EUR$2,600USD£2,082GBP
- Report
- April 2021
China
From €2468EUR$2,600USD£2,082GBP
- Report
- November 2023
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
From €3323EUR$3,500USD£2,803GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3323EUR$3,500USD£2,803GBP
- Report
- March 2024
- 92 Pages
From €3275EUR$3,450USD£2,763GBP

Trastuzumab is a monoclonal antibody used to treat certain types of breast cancer. It is used to treat HER2-positive breast cancer, which is a type of cancer that has a higher than normal amount of a protein called HER2. Trastuzumab works by blocking the HER2 protein, which helps to slow or stop the growth of cancer cells. It is usually given in combination with other chemotherapy drugs. Trastuzumab is typically given intravenously, and can be used in both early and advanced stages of breast cancer. It is also used to reduce the risk of recurrence in patients who have already been treated for HER2-positive breast cancer.
Trastuzumab is a widely used drug in the treatment of breast cancer, and is available from a number of pharmaceutical companies. Some of the companies that produce trastuzumab include Roche, Merck, Pfizer, and Amgen. Show Less Read more